Sector ratings Laboratorios Farmaceuticos Rovi, S.A. OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 03:50:50 26/11/24 am AEDT			5-day change	1st Jan Change
65.86 ^USD	-27.31%		-.--%	-

23/07	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
23/07	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
ELI LILLY AND COMPANY	1,067B		A
JOHNSON & JOHNSON	635B		BBB
ABBVIE INC.	458B		AA	-
ROCHE HOLDING AG	347B		AA
NOVARTIS AG	295B		AAA
ASTRAZENECA PLC	262B		A
NOVO NORDISK A/S	216B		A
AMGEN INC.	203B		A
GILEAD SCIENCES, INC.	161B		AA
PFIZER INC.	140B		A
BRISTOL-MYERS SQUIBB COMPANY	127B		A
VERTEX PHARMACEUTICALS INCORPORATED	121B		AA
SANOFI	104B		AA
GSK PLC	102B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	74.54B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	55.09B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	52.08B		AA
BAYER AG	51.52B		AA
Average	238.65B		AA
Weighted average by Cap.			AA